Catalyst
Slingshot members are tracking this event:
AMAG Pharmaceuticals aiming to release top-line data on (AMAG) Feraheme, treatment for Adults with Iron Deficiency Anemia (IDA) in Q2 of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMAG | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 02, 2017
Occurred Source:
https://www.amagpharma.com/news/amag-announces-positive-topline-data-from-phase-3-feraheme-ferumoxytol-label-expansion-study/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Iron Deficiency Anemia, Topline Data
